AMGN Price / Book | Amgen Inc.

Amgen Inc. (AMGN) Price / Book

2026-09-03: Price/Book Ratio 20.55.
2026-06-30: Price/Book Ratio 16.75.
2026-03-31: Price/Book Ratio 20.66.
2025-12-31: Price/Book Ratio 20.37.

Historical market capitalization divided by filed shareholder equity.

Available history: 2008-12-31 to 2026-09-03
Data captured: 2026-09-04

Historical Price/Book Ratio

Date	Price/Book Ratio
2026-09-03	20.55
2026-06-30	16.75
2026-03-31	20.66
2025-12-31	20.37
2025-09-30	15.8
2025-06-30	20.23
2025-03-31	26.99
2024-12-31	23.81
2024-09-30	23.01
2024-06-30	28.33
2024-03-31	30.37
2023-12-31	24.74
2023-09-30	18.78
2023-06-30	17.51
2023-03-31	24.15
2022-12-31	38.31
2022-09-30	32.92
2022-06-30	53.8
2022-03-31	141.03
2021-12-31	18.75
2021-09-30	14.62
2021-06-30	16.84
2021-03-31	15.34
2020-12-31	14.13
2020-09-30	13.53
2020-06-30	12.98
2020-03-31	12.57
2019-12-31	14.74
2019-09-30	10.56
2019-06-30	10.28
2019-03-31	10.78
2018-12-31	9.81
2018-09-30	9.38
2018-06-30	8.04
2018-03-31	7.27
2017-12-31	4.98
2017-09-30	4.2
2017-06-30	3.97
2017-03-31	3.94
2016-12-31	3.61
2016-09-30	4.04
2016-06-30	3.78
2016-03-31	3.93
2015-12-31	4.36
2015-09-30	3.73
2015-06-30	4.24
2015-03-31	4.59
2014-12-31	4.7
2014-09-30	4.22
2014-06-30	3.69
2014-03-31	4.11
2013-12-31	3.9
2013-09-30	3.88
2013-06-30	3.61
2013-03-31	3.94
2012-12-31	3.42
2012-09-30	3.25
2012-06-30	2.92
2012-03-31	2.81
2011-12-31	2.68
2011-09-30	2.05
2011-06-30	2.1
2011-03-31	2
2010-12-31	2.14
2010-09-30	2.18
2010-06-30	2.17
2010-03-31	2.59
2009-12-31	2.48
2009-09-30	2.68
2009-06-30	2.52
2008-12-31	2.9

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
GILEAD SCIENCES, INC. (GILD)	United States	$185.522B	-48.37
Moderna, Inc. (MRNA)	United States	$77.819B	-8.86
Revolution Medicines, Inc. (RVMD)	United States	$42.805B	-22.69
BIOGEN INC. (BIIB)	United States	$33.427B	19.60
EXELIXIS, INC. (EXEL)	United States	$14.358B	16.15
NEUROCRINE BIOSCIENCES INC (NBIX)	United States	$14.131B	24.25
HALOZYME THERAPEUTICS, INC. (HALO)	United States	$13.083B	21.59
Twist Bioscience Corp (TWST)	United States	$11.540B	-47.21
BIO-TECHNE Corp (TECH)	United States	$11.379B	74.68
REPLIGEN CORP (RGEN)	United States	$10.755B	185.31